We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Recommendations on HTLV-1 based on a review of the evidence for prevalence and transmission and the effectiveness of standard infection prevention and control.
This publication (Documents of the NRPB volume 12 number 3) contains the recommendations of the Second UK Working Group on stable iodine prophylaxis.
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Information for clinicians on diagnosis and notification of Shiga toxin-producing Escherichia coli (STEC) and haemolytic uraemic syndrome (HUS).
These forms are for GPs or other clinicians to fill out, to follow up cases of invasive haemophilus influenzae disease.
Data on the real-world efficacy of the COVID-19 vaccines.
Vaccine recommendations for adults and children during periods of vaccine supply constraints.
Clarification for the interpretation of the new elements within the Veterinary Medicines Regulations (VMRs), as amended, relating to combating antimicrobial resistance (AMR).
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
How investigators and sponsors should manage clinical trials during COVID-19
TACO is one of the most common causes of transfusion-related deaths in the UK and cases have increased substantially in recent years. Identifying risk factors for TACO prior to transfusion allows initiation of appropriate mitigating measures.
UK Health Security Agency's laboratories provide a comprehensive range of microbiological tests and services.
Guidance and information about high consequence infectious diseases and their management in England.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).